Brief: Titan Pharmaceuticals Gets Additional 180 Days To Regain Compliance With Nasdaq Listing Rule
06/06/2023 21:42
June 6 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS- ON JUNE 5, GOT LETTER FROM NASDAQ
THAT CO
HAD BEEN GRANTED ADDITIONAL 180 DAYS TO REGAIN COMPLIANCE WITH
NASDAQ LISTING RULE
Source text for Eikon: ID:
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.